Kathleen Borthwick

Director of Finance/CFO at PASSAGE BIO, INC.

Net worth: 31 170 $ as of 2026-05-30

50 year

Health Technology

Consumer Services

Profile

Kathleen Borthwick is currently Chief Financial Officer at Passage Bio, Inc. since 2024.
Formerly, Ms. Borthwick was Head-Business Development at Johnson & Johnson Services, Inc. Education includes an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PASSAGE BIO, INC. 0.17%	2026-03-15	5,402 ( 0.17% )	31 170 $	2026-05-30

Kathleen Borthwick active positions

Companies	Position	Start
PASSAGE BIO, INC.	Director of Finance/CFO	2023-07-27

All active positions of Kathleen Borthwick

Former positions of Kathleen Borthwick

Companies	Position	End
Johnson & Johnson Services, Inc. Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company	Corporate Officer/Principal	-

See the detail of Kathleen Borthwick's experience

Training of Kathleen Borthwick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kathleen Borthwick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Johnson & Johnson Services, Inc. Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company	Health Technology
Tuck School of Business at Dartmouth Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Passage Bio, Inc. Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders	Health Technology